{"entity":{"type":"insider","cik":"0001296999","url":"/insider/0001296999","json_url":"/insider/0001296999.json","name":"Arkowitz David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":23,"first":"2004-07-29","last":"2025-01-13","span_basis":"filed_date"},"name_variants":[{"name":"Arkowitz David","source":"filing","n_filings":23,"first_seen":"2004-07-29","last_seen":"2025-01-13"}],"transactions":[{"id":4547566,"accession":"0001104659-25-003061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-003061","line_url":"/filing/0001104659-25-003061#line-1","is_derivative":false,"issuer_cik":"0001296999","issuer_name":"iBio, Inc.","issuer_ticker":"IBIO","issuer_name_source":null,"issuer_url":"/issuer/0001296999","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18382.0,"shares_display":"18,382","price_per_share":2.72,"price_display":"2.72","price_state":"stated","total_value":49999.04,"total_display":"49,999.04","shares_owned_after":18382.0,"shares_owned_after_display":"18,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-10","filed_date":"2025-01-13","scope":"insider"},{"id":2302757,"accession":"0000950170-24-016687","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-016687","line_url":"/filing/0000950170-24-016687#line-2","is_derivative":false,"issuer_cik":"0001296999","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001296999","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3939.0,"shares_display":"3,939","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":4254.12,"total_display":"4,254.12","shares_owned_after":182442.0,"shares_owned_after_display":"182,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-16","scope":"insider"},{"id":8135961,"accession":"0000899243-23-020077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-020077","line_url":"/filing/0000899243-23-020077#line-2","is_derivative":false,"issuer_cik":"0001296999","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001296999","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4066.0,"shares_display":"4,066","price_per_share":1.35,"price_display":"1.35","price_state":"stated","total_value":5489.1,"total_display":"5,489.10","shares_owned_after":175756.0,"shares_owned_after_display":"175,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-30","filed_date":"2023-10-31","scope":"insider"},{"id":5522350,"accession":"0001209191-21-032103","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-032103","line_url":"/filing/0001209191-21-032103#line-1","is_derivative":false,"issuer_cik":"0001296999","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001296999","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2229.0,"shares_display":"2,229","price_per_share":7.23,"price_display":"7.23","price_state":"stated","total_value":16115.67,"total_display":"16,115.67","shares_owned_after":220719.0,"shares_owned_after_display":"220,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-10","filed_date":"2021-05-12","scope":"insider"},{"id":4137124,"accession":"0001209191-21-002558","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-002558","line_url":"/filing/0001209191-21-002558#line-1","is_derivative":false,"issuer_cik":"0001296999","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001296999","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6073.0,"shares_display":"6,073","price_per_share":11.13,"price_display":"11.13","price_state":"stated","total_value":67592.49,"total_display":"67,592.49","shares_owned_after":151048.0,"shares_owned_after_display":"151,048","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-05","filed_date":"2021-01-07","scope":"insider"},{"id":3166206,"accession":"0001209191-20-028249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-028249","line_url":"/filing/0001209191-20-028249#line-1","is_derivative":false,"issuer_cik":"0001296999","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001296999","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2413.0,"shares_display":"2,413","price_per_share":10.88,"price_display":"10.88","price_state":"stated","total_value":26253.44,"total_display":"26,253.44","shares_owned_after":117068.0,"shares_owned_after_display":"117,068","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-07","filed_date":"2020-05-11","scope":"insider"},{"id":2624454,"accession":"0001209191-20-002279","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-002279","line_url":"/filing/0001209191-20-002279#line-1","is_derivative":false,"issuer_cik":"0001296999","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001296999","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3095.0,"shares_display":"3,095","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":88481.0,"shares_owned_after_display":"88,481","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-03","filed_date":"2020-01-07","scope":"insider"},{"id":8204704,"accession":"0001209191-19-033898","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-033898","line_url":"/filing/0001209191-19-033898#line-1","is_derivative":false,"issuer_cik":"0001296999","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001296999","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":11.0507,"price_display":"11.05","price_state":"stated","total_value":27626.75,"total_display":"27,626.75","shares_owned_after":89424.0,"shares_owned_after_display":"89,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-31","filed_date":"2019-06-03","scope":"insider"},{"id":7947035,"accession":"0001209191-19-029970","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-029970","line_url":"/filing/0001209191-19-029970#line-1","is_derivative":false,"issuer_cik":"0001296999","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001296999","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":11.99,"price_display":"11.99","price_state":"stated","total_value":47960.0,"total_display":"47,960.00","shares_owned_after":86924.0,"shares_owned_after_display":"86,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-13","filed_date":"2019-05-15","scope":"insider"},{"id":7871185,"accession":"0001209191-19-028497","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-028497","line_url":"/filing/0001209191-19-028497#line-1","is_derivative":false,"issuer_cik":"0001296999","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001296999","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2248.0,"shares_display":"2,248","price_per_share":10.06,"price_display":"10.06","price_state":"stated","total_value":22614.88,"total_display":"22,614.88","shares_owned_after":82924.0,"shares_owned_after_display":"82,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-08","filed_date":"2019-05-09","scope":"insider"},{"id":6479601,"accession":"0001209191-18-058085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-058085","line_url":"/filing/0001209191-18-058085#line-1","is_derivative":false,"issuer_cik":"0001296999","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001296999","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":16.5554,"price_display":"16.56","price_state":"stated","total_value":66221.6,"total_display":"66,221.60","shares_owned_after":48250.0,"shares_owned_after_display":"48,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-09","filed_date":"2018-11-13","scope":"insider"},{"id":6765019,"accession":"0001209191-18-046163","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-046163","line_url":"/filing/0001209191-18-046163#line-1","is_derivative":false,"issuer_cik":"0001296999","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001296999","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":23.42,"price_display":"23.42","price_state":"stated","total_value":93680.0,"total_display":"93,680.00","shares_owned_after":44250.0,"shares_owned_after_display":"44,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-09","filed_date":"2018-08-10","scope":"insider"},{"id":4447324,"accession":"0001209191-17-047862","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-047862","line_url":"/filing/0001209191-17-047862#line-2","is_derivative":false,"issuer_cik":"0001296999","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001296999","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2300.0,"shares_display":"2,300","price_per_share":12.24,"price_display":"12.24","price_state":"stated","total_value":28152.0,"total_display":"28,152.00","shares_owned_after":19386.0,"shares_owned_after_display":"19,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-04","filed_date":"2017-08-07","scope":"insider"},{"id":4447318,"accession":"0001209191-17-047862","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-047862","line_url":"/filing/0001209191-17-047862#line-1","is_derivative":false,"issuer_cik":"0001296999","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001296999","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":12.25,"price_display":"12.25","price_state":"stated","total_value":2450.0,"total_display":"2,450.00","shares_owned_after":17086.0,"shares_owned_after_display":"17,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-04","filed_date":"2017-08-07","scope":"insider"},{"id":9283597,"accession":"0001317757-11-000019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001317757-11-000019","line_url":"/filing/0001317757-11-000019#line-1","is_derivative":false,"issuer_cik":"0001296999","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0001296999","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (EVP, CFO, CBO)","officer_title":"EVP, CFO, CBO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":13.23,"price_display":"13.23","price_state":"stated","total_value":19845.0,"total_display":"19,845.00","shares_owned_after":1806.0,"shares_owned_after_display":"1,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-31","filed_date":"2011-06-01","scope":"insider"},{"id":9135314,"accession":"0001317757-11-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001317757-11-000017","line_url":"/filing/0001317757-11-000017#line-1","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (EVP, CFO and CBO)","officer_title":"EVP, CFO and CBO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":13.23,"price_display":"13.23","price_state":"stated","total_value":19845.0,"total_display":"19,845.00","shares_owned_after":1806.0,"shares_owned_after_display":"1,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-31","filed_date":"2011-06-01","scope":"insider"},{"id":9124758,"accession":"0001317757-11-000007","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001317757-11-000007","line_url":"/filing/0001317757-11-000007#line-3","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (EVP, Chief Financial Officer)","officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2205.0,"shares_display":"2,205","price_per_share":17.06,"price_display":"17.06","price_state":"stated","total_value":37617.3,"total_display":"37,617.30","shares_owned_after":306.0,"shares_owned_after_display":"306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-24","filed_date":"2011-02-28","scope":"insider"},{"id":9124757,"accession":"0001317757-11-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001317757-11-000007","line_url":"/filing/0001317757-11-000007#line-2","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (EVP, Chief Financial Officer)","officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":17.1,"price_display":"17.10","price_state":"stated","total_value":8550.0,"total_display":"8,550.00","shares_owned_after":2511.0,"shares_owned_after_display":"2,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-24","filed_date":"2011-02-28","scope":"insider"},{"id":7226104,"accession":"0001317757-10-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001317757-10-000020","line_url":"/filing/0001317757-10-000020#line-2","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (EVP, CFO and CBO)","officer_title":"EVP, CFO and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15750.0,"shares_display":"15,750","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":1136.0,"shares_owned_after_display":"1,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-05","filed_date":"2010-08-06","scope":"insider"},{"id":7652743,"accession":"0001317757-10-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001317757-10-000017","line_url":"/filing/0001317757-10-000017#line-1","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (EVP, CFO and CBO)","officer_title":"EVP, CFO and CBO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":658.0,"shares_display":"658","price_per_share":27.06,"price_display":"27.06","price_state":"stated","total_value":17805.48,"total_display":"17,805.48","shares_owned_after":1886.0,"shares_owned_after_display":"1,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-28","filed_date":"2010-06-01","scope":"insider"},{"id":5919629,"accession":"0001317757-09-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001317757-09-000023","line_url":"/filing/0001317757-09-000023#line-1","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (CFO and Chief Business Officer)","officer_title":"CFO and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":172.0,"shares_display":"172","price_per_share":31.78,"price_display":"31.78","price_state":"stated","total_value":5466.16,"total_display":"5,466.16","shares_owned_after":478.0,"shares_owned_after_display":"478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-01","filed_date":"2009-12-02","scope":"insider"},{"id":5656117,"accession":"0001317757-09-000019","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001317757-09-000019","line_url":"/filing/0001317757-09-000019#line-2","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (CFO and Chief Business Officer)","officer_title":"CFO and Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4459.0,"shares_display":"4,459","price_per_share":43.415,"price_display":"43.42","price_state":"stated","total_value":193587.485,"total_display":"193,587.48","shares_owned_after":306.0,"shares_owned_after_display":"306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-12","filed_date":"2009-11-12","scope":"insider"},{"id":5656116,"accession":"0001317757-09-000019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001317757-09-000019","line_url":"/filing/0001317757-09-000019#line-1","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (CFO and Chief Business Officer)","officer_title":"CFO and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":529.0,"shares_display":"529","price_per_share":25.61,"price_display":"25.61","price_state":"stated","total_value":13547.69,"total_display":"13,547.69","shares_owned_after":4765.0,"shares_owned_after_display":"4,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-06-02","filed_date":"2009-11-12","scope":"insider"},{"id":3965237,"accession":"0001104659-08-039713","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-08-039713","line_url":"/filing/0001104659-08-039713#line-1","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (CFO, CBO, and Exec. VP)","officer_title":"CFO, CBO, and Exec. VP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":37.5,"price_display":"37.50","price_state":"stated","total_value":37500.0,"total_display":"37,500.00","shares_owned_after":3486.0,"shares_owned_after_display":"3,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-11","filed_date":"2008-06-13","scope":"insider"},{"id":3965208,"accession":"0001104659-08-030379","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001104659-08-030379","line_url":"/filing/0001104659-08-030379#line-8","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (CFO and Chief Business Officer)","officer_title":"CFO and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":40.38,"price_display":"40.38","price_state":"stated","total_value":12114.0,"total_display":"12,114.00","shares_owned_after":1756.0,"shares_owned_after_display":"1,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-05","filed_date":"2008-05-06","scope":"insider"},{"id":3965207,"accession":"0001104659-08-030379","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001104659-08-030379","line_url":"/filing/0001104659-08-030379#line-7","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (CFO and Chief Business Officer)","officer_title":"CFO and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":40.37,"price_display":"40.37","price_state":"stated","total_value":8074.0,"total_display":"8,074.00","shares_owned_after":1356.0,"shares_owned_after_display":"1,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-05","filed_date":"2008-05-06","scope":"insider"},{"id":3965206,"accession":"0001104659-08-030379","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-08-030379","line_url":"/filing/0001104659-08-030379#line-6","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (CFO and Chief Business Officer)","officer_title":"CFO and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":40.39,"price_display":"40.39","price_state":"stated","total_value":4039.0,"total_display":"4,039.00","shares_owned_after":2056.0,"shares_owned_after_display":"2,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-05","filed_date":"2008-05-06","scope":"insider"},{"id":3965205,"accession":"0001104659-08-030379","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-08-030379","line_url":"/filing/0001104659-08-030379#line-5","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (CFO and Chief Business Officer)","officer_title":"CFO and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":40.39,"price_display":"40.39","price_state":"stated","total_value":4039.0,"total_display":"4,039.00","shares_owned_after":1456.0,"shares_owned_after_display":"1,456","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-05","filed_date":"2008-05-06","scope":"insider"},{"id":3965204,"accession":"0001104659-08-030379","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-08-030379","line_url":"/filing/0001104659-08-030379#line-4","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (CFO and Chief Business Officer)","officer_title":"CFO and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":40.38,"price_display":"40.38","price_state":"stated","total_value":4038.0,"total_display":"4,038.00","shares_owned_after":1156.0,"shares_owned_after_display":"1,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-05","filed_date":"2008-05-06","scope":"insider"},{"id":3965203,"accession":"0001104659-08-030379","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-08-030379","line_url":"/filing/0001104659-08-030379#line-3","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (CFO and Chief Business Officer)","officer_title":"CFO and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":40.37,"price_display":"40.37","price_state":"stated","total_value":4037.0,"total_display":"4,037.00","shares_owned_after":1956.0,"shares_owned_after_display":"1,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-05","filed_date":"2008-05-06","scope":"insider"},{"id":3965202,"accession":"0001104659-08-030379","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-08-030379","line_url":"/filing/0001104659-08-030379#line-2","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (CFO and Chief Business Officer)","officer_title":"CFO and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":40.37,"price_display":"40.37","price_state":"stated","total_value":4037.0,"total_display":"4,037.00","shares_owned_after":1856.0,"shares_owned_after_display":"1,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-05","filed_date":"2008-05-06","scope":"insider"},{"id":219044,"accession":"0001209191-04-037993","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-04-037993","line_url":"/filing/0001209191-04-037993#line-1","is_derivative":false,"issuer_cik":"0001093649","issuer_name":"IDENIX PHARMACEUTICALS INC","issuer_ticker":"IDIX","issuer_name_source":null,"issuer_url":"/issuer/0001093649","owner_cik":"0001296999","owner_name":"Arkowitz David","owner_url":"/insider/0001296999","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":112000.0,"total_display":"112,000.00","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-07-27","filed_date":"2004-07-29","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":21,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001420720","name":"iBio, Inc.","url":"/issuer/0001420720","role":"Director","n_filings":1,"first_seen":"2025-01-13","last_seen":"2025-01-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001609809","name":"Seres Therapeutics, Inc.","url":"/issuer/0001609809","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2023-10-31","last_seen":"2024-02-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001419600","name":"Flexion Therapeutics Inc","url":"/issuer/0001419600","role":"Officer (Chief Financial Officer)","n_filings":9,"first_seen":"2018-08-10","last_seen":"2021-05-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001566373","name":"Spring Bank Pharmaceuticals, Inc.","url":"/issuer/0001566373","role":"Director","n_filings":1,"first_seen":"2017-08-07","last_seen":"2017-08-07"},{"type":"issuer","type_label":"ISSUER","cik":"0000792977","name":"AMAG PHARMACEUTICALS INC.","url":"/issuer/0000792977","role":"Officer (EVP, CFO, CBO)","n_filings":9,"first_seen":"2008-05-06","last_seen":"2011-06-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001093649","name":"IDENIX PHARMACEUTICALS INC","url":"/issuer/0001093649","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2004-07-29","last_seen":"2004-07-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001296999","retrieved_at":"2026-08-21T04:21:31+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}